Talphera Inc.
TLPH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.46M
Close$
$-0.01
101.4% downside
Current Fair Value
101.4% downsideOvervalued by 101.4% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $53.46 Million |
|---|---|
| Enterprise Value | $52.72 Million |
| Earnings per Share | $-0.34 |
| Beta | 0.68 |
| Outstanding Shares | 75,526,900 |
Return
| Return on Equity | -104.65% |
|---|---|
| Return on Assets | -56.24% |
| Return on Invested Capital | -67.21% |
Valuation & Multiples
| P/E Ratio | -3.23 |
|---|---|
| PEG | -13.68 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 52720.97 |
| Enterprise Value to EBIT | -3.47 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.06
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.88, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.8784▼ 27.72% |
|---|---|
| Total Calls | 100,300▲ 6.14% |
| Total Puts | 88,100▼ 19.32% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 31.60%▼ 19.96% |
|---|---|
| Total Invested | $24.59M▲ 50.54% |
| Investors Holding | 55▲ 4.00% |
About Talphera Inc.
31,000 employees
CEO: Vincent Angotti
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (kno...